Bulut et al. also investigated the impact of delayed anti-VEGF treatment for retinal diseases and found that a six-month delay in intravitreal injection of loading doses of anti-VEGF had adverse effects in macular edema from RVO [48]. This evidence concerns the gene VEGFA and macular retinal edema.